Evaluation of Treatment Adherence and Uncontrolled Blood Sugar Prevalence in Type 2 Diabetes Mellitus Patients at a Tertiary Care Centre in Rajnandgaon, Chhattisgarh, India.
Keywords:
Keywords: Glycemic Control, Type 2 Diabetes, Prevalence, Rural Healthcare.Abstract
ABSTRACT
Background
Diabetes mellitus is a growing global health challenge, with diabetic peripheral neuropathy (DPN) emerging
as one of its serious complications. DPN contributes significantly to morbidity, including debilitating pain, foot
ulcers, and increased risk of amputation, particularly among populations with limited healthcare resources.
Methods
A descriptive, cross-sectional study was conducted at the Government Medical College Hospital in
Rajnandgaon, involving 203 patients aged 21 years and above with type 2 diabetes mellitus (T2DM) diagnosed
for at least one year. The Michigan Neuropathy Screening Instrument (MNSI) was employed to assess DPN,
and socio-demographic along with clinical data were systematically collected. Data analysis using SPSS
revealed associations between DPN and various risk factors.
Results
The prevalence of DPN among the study cohort was substantial. Statistical evaluation indicated significant
correlations between the presence of neuropathy and factors such as prolonged duration of diabetes,
advanced age, and suboptimal glycemic control. These findings highlight the vulnerability of diabetic patients
to nerve damage over time due to sustained metabolic imbalances.
Conclusions
The considerable prevalence of DPN underscores the critical need for routine screening and early intervention
in diabetic care, particularly within resource-constrained settings. Implementing standardized diagnostic
tools like the MNSI can facilitate timely detection and management, thereby reducing complications and
improving quality of life. Tailored healthcare strategies focused on optimal glycemic control are essential to
address the socio-economic and clinical challenges posed by DPN.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.